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Abstract 
Objective: To provide an overview of cognitive rehabilitation approaches for cognitive 
dysfunction after cancer and cancer treatment.   
Data Sources: Review and synthesis of empirical articles. 
Conclusion: Cognitive rehabilitation approaches, including cognitive behavioral therapy (CBT) 
and cognitive training (CT), for cognitive dysfunction appear feasible to deliver, satisfactory to 
participants, and have shown promising results in cancer survivors. Future research is needed to 
address optimal dose, delivery method, access, cost and the vulnerable aging cancer survivor 
population.  
Implications for Nursing Practice: Oncology nurses must understand the available evidence and 
be able to provide information and options to cancer survivors to address cognitive changes after 
cancer.  
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Background 
Cancer survivors often incur a myriad of lingering symptoms after cancer and cancer 
treatment, including cognitive dysfunction. 1,2 Cognitive dysfunction, defined as cognitive 
changes that negatively affect higher-order mental processes in one or more cognitive domains, 
including attention and concentration, learning and memory, information processing speed, 
visuospatial skill, language, and executive function, 3 has been shown to be a prevalent, 
bothersome, and potentially debilitating symptom in a subset of cancer survivors. 1 Researchers 
have noted that cancer survivors with cognitive dysfunction also report decreased social 
interactions, 4 poorer functional 5 and work ability, 6 as well as, overall poorer health-related 
quality of life. 1,5,7  
Given the debilitating nature and potentially long-term adverse effects of cancer and 
cancer treatment-related cognitive dysfunction, identifying effective treatment options are 
necessary. Research in this area has been hampered by the lack of a clear etiology. 1 Underlying 
mechanisms of cognitive dysfunction in cancer survivors are unclear and most likely multi-
factorial. 8-11 However, health care providers, including advance practice nurses and nurse 
clinicians, have an obligation to understand the current evidence and options available to address 
cognitive dysfunction in cancer survivors. 12  
The National Comprehensive Cancer Network (NCCN) Survivorship Guidelines® 
provide information regarding the assessment, screening, and treatment of cognitive dysfunction. 
13 This guideline identifies cognitive rehabilitation as a first-line intervention to address cognitive 
dysfunction in cancer survivors. However, it stops short of defining or sharing the supporting 
evidence for its recommendations or the role nurses may have in developing and implementing 
these evidence based strategies.  
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Cognitive rehabilitation includes behavioral interventions that have been shown, to not 
only improve cognitive function, but also have included goal attainment behavior, self-efficacy, 
memory enhancement, and problem solving techniques in patients with traumatic brain injury. 14 
Cognitive rehabilitative approaches have included programs in ‘cognitive training’(CT) or ‘brain 
training’ and those that use ‘strategy training’ also known as ‘cognitive behavioral therapy’ 
(CBT) and could include psycho-educational approaches. Cognitive rehabilitation therapy has 
long been used to address cognitive dysfunction in individuals with cognitive injury. 15 However, 
less is known regarding the efficacy of cognitive rehabilitation approaches (CBT and CT) in 
cancer survivors. Therefore, the purpose of this integrative review was to provide an overview of 
cognitive rehabilitation approaches for cognitive dysfunction after cancer and cancer treatment. 
In addition, the nurse’s role in addressing cognitive dysfunction in cancer survivors will be 
emphasized. Advance practice nurses and oncology nurse clinicians are often the first healthcare 
providers in which cancer survivors report cognitive changes, and; therefore, they must have the 
requisite information to support cancer survivors effectively and provide optimal care. 12 
Methods 
The Whittemore and Knafl 16  integrative review method was used to conduct the review 
and included problem identification, literature search, data evaluation, and graphic presentations. 
Databases searched were PubMed, Med line and PsychINFO. Search terms used were “cognitive 
impairment” OR “cognitive dysfunction” AND “cognitive rehabilitation” Or “cognitive training” 
AND “cancer” or “cancer survivor.” Search limitations were English language and publication 
year 2000 to March, 2019.  
Inclusion criteria were peer-reviewed primary interventional research articles that 
included cognitive rehabilitation approaches for cancer survivors. Review articles were excluded, 
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but reference lists of relevant reviews were hand-searched for further citations. After reviewing 
article titles and abstracts and eliminating duplicate articles, full-text articles were obtained based 
on title and abstract evaluation, and criteria were applied to determine article eligibility. The 
studies selected for the review were limited to those empirical manuscripts that were in English 
and examined cognitive rehabilitative approaches to address cognitive dysfunction in adult 
cancer survivors. Cognitive impairment in pediatric patients were not addressed in this review 
due to the specificity of cognitive and development issues found in children. 
Data was extracted from articles that met criteria. Data was reduced, grouped, and 
compared among articles. Articles were separated into the types of cognitive rehabilitation 
approaches used (CBT and CT) specific cognitive outcome measures were identified, results 
were condensed, and outcomes presented.  
Results  
A total of 1466 manuscripts were identified in the first initial search. Duplicate 
manuscripts and those that did not meet the inclusion criteria were not retained. A total of 27 
manuscripts met the inclusion criteria and were identified for review and synthesis. Figure 1 
presents the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
diagram. 
Cognitive Rehabilitation Approaches 
The 27 cognitive rehabilitation interventional studies that meet the eligibility criteria 
included a total of 1543 participants, who were predominately middle-aged (mid-fifties), highly 
educated and female breast cancer survivors. In fact, 12 or 46% of the studies included in this 
review focused solely on breast cancer survivors, and of those with mixed cancer diagnoses, 
most were breast cancer survivors. Intervention studies included randomized controlled trials 
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(n=18), partially randomized, quasi or non-randomized controlled trials (n=3), single arm studies 
(n=5) and one retrospective assessment. Most of the research was limited by small samples 
(n˂100) and inferior study designs (no control arm or waitlist/non-contact control arms versus 
attention control comparisons). Cognitive domains assessed in these studies included primarily 
memory, attention, speed of processing, and executive function, which is consistent with 
previous meta-analyses identifying these as areas of primary concern by cancer survivors with 
cognitive dysfunction. 17-19  
Table 1 displays the author, year published, cancer population (if known), design, type of 
cognitive rehabilitation approach, cognitive domains assessed, and cognitive outcomes. 
Cognitive rehabilitative approaches included CBT with or without psychoeducational programs 
and CT approaches. The following section will provide an integrated summary of the cognitive 
rehabilitation approaches utilized in these studies and their outcomes.   
Cognitive-Behavioral Training  
CBT programs are designed to improve or restore mental function through behaviorally 
orientated programs that may include retraining of lost cognitive abilities and compensatory 
strategies or more inclusive behavioral programs such as social support and self-efficacy. 20 
While CBT does not include cognitive behavioral psychotherapy, generally it does focus on 
eliminating negative thoughts and beliefs, establishing goals, developing problem solving skills 
and/or implementing new behaviors to cope with cognitive dysfunction. Activities can also 
include psychoeducation, relaxation and/or mindfulness strategies. These activities can be 
delivered in-person, over the telephone, via video conference, or the internet. 21  
Eleven studies were identified that focused on understanding the implications of CBT on 
cognitive dysfunction in cancer survivors. 22-32 The sample sizes in these studies were quite 
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small. In fact, in the 11 total trials, there were a total of 442 participants and no study had more 
than 100 participants. The composition of the participants varied with 6 studies offering the 
intervention to a mixed group of survivors, 23,24,28,30-32 4 to breast cancer survivors, 25-27,29 and 
one study focusing primarily on brain tumor patients. 22 Interventions focused on 
psychoeducation, 28-30 self-efficacy, 23,24,30 self-regulation, 25-27 and mindfulness techniques. 32 
All of the studies included in this review found some positive cognitive intervention effects of 
CBT. The majority of the positive cognitive outcomes were noted in either subjective (self-
report) or neurocognitive test performance, but often results were mixed or not sustained beyond 
initial post-treatment time frames (Refer to Table 1 for details). Only one early study with 
primary brain tumor patients noted improvements in independence and productivity which were 
objectively assessed by clinicians. 22 The majority of the intervention studies were also identified 
to be satisfactory by participant reports. 26  
Notably, work in this field has primarily been advanced by three distinct research groups 
who have conducted multiple studies (n=7 of the 11 studies) in the effort to test and/or enhance 
CBT programs to address cognitive dysfunction in cancer survivors. 23-28,30 McDougall and 
colleagues 23 were the first to test the efficacy of a memory training and self-efficacy program in 
a large sample of elderly (n=78 with a subset of 11 cancer patients). These participants reported 
improvement in perceived cognitive function, memory efficacy and meta-memory (or perceived 
capability, self-awareness and strategies to aid memory). In a follow-up pilot study, these 
researchers found improvements in perceived cognitive function (memory ability), as well as, 
improvement in visual memory performance in the intervention group (n = 8) compared to 
controls (n = 14). 24 Ferguson and colleagues 26,27,33 conducted the most studies in this area, 
completing three separate studies piloting the Memory Attention Adaptation Training (MAAT) 
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program, which included memory, attention and self-awareness training. In their first one-arm 
trial, improvement was noted in perceived cognitive function as well as objectively measured 
verbal memory, executive functioning and psychomotor performance. 33 In the 2012 follow-up 
randomized clinical trial, breast cancer survivors who were randomly assigned to the MAAT 
program (n = 19) demonstrated greater improvements in verbal memory compared to those in the 
waitlist control (n =21). 26  However, in this follow-up study, no improvement was noted in 
perceived cognitive concerns. Finally, Ferguson and colleagues 27 tested the MAAT program 
delivered by video conferencing to breast cancer survivors. In this final pilot study, they found 
improvement in processing speed immediately post-intervention and improvement in perceived 
cognitive dysfunction at a 2-month follow-up compared to controls. However, there was no 
demonstrated improvement in memory at either time point. The authors identify that the MAAT 
training program could be delivered via video conferencing; thus, increasing access to rural 
survivors who are often unable to participate. However, this intervention unlike others required a 
licensed psychiatrist to perform the training adding cost concerns for under- or un-insured cancer 
survivors. 25-27 The third research team conducted two CBT studies, which combined 
psychoeducation and problem-solving approaches to address cognitive dysfunction in a mixed 
group of cancer survivors. In the first trial by this team, Shuurs and Green 28 noted improvement 
in immediate and delayed memory and visuospatial skills for up to 3 months post-intervention. 
In a follow-up study, King and Green 30 used the same CBT program and failed to note 
significant improvements in memory, but did find improvements in perceived cognitive function 
and information processing speed for up to 3 months post-intervention, as well as, improved 
cognitive self-efficacy. The remaining studies used a combination of approaches including 
compensatory strategies, psychoeducation, 29 mindfulness, 32 and one CBT study attempted to 
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ameliorate cancer-related fatigue as a mechanism to improve perceived cognitive function in 
cancer survivors 31 with positive results (See Table 1).  
Cognitive Training Programs for Cognitive Dysfunction   
CT programs focus specifically on structured practice on cognitive tasks with the intent 
to improve and/or maintain cognitive function. Based on Hallock and colleagues 34, 
characteristics of cognitive training include repetitive, standardized, problem-orientated tasks 
that target specific cognitive domains to restore impaired skills. CT can be delivered on an 
individual basis or group setting and/or be computer assisted.  
Sixteen studies (including 1101 cancer survivors) were found that focused primarily on 
the effects of CT to improve cognitive functioning in cancer patients. Becker and colleagues 35 
combined computerized CT with 6-weekly group sessions to improve cognitive dysfunction (See 
Table 1). Participants in these training programs included breast cancer survivors (n= 7), 35-41 
primary brain tumor patients (n=5), 42-46 prostate cancer survivors (n=1), 47 and mixed cancer 
groups (n=3). 14,48,49 The training programs differed in regards to content and length, but most of 
the programs focused on memory training, speed of processing or problem solving (executive 
functioning). Delivery method also varied among the studies with some providing individual 
training and others provided group sessions. Computerized CT programs were used in a number 
of studies, with 5 studies using the InSight program known now as BrainHQ from Posit 
Science®. 6,14,35,41,47 See Table 1 for further descriptions.   
In summary, the majority of CT programs reviewed noted improvements in subjective 
and/or objective cognitive performance on neurocognitive tests. In fact, all but one study noted 
intervention effects of CT. Poppelreuter and colleagues 48 were the only research team that did 
not find significant intervention effects in a mixed group of in-patient cancer rehabilitation 
COGNITIVE REHABILITATION 
patients; however results were hypothesized to have been confounded with overall recovery. 
Overall, in the cognitive training studies reviewed, significant intervention effects (small to 
moderate effect sizes) were noted with CT. Positive intervention effects were noted primarily in 
the cognitive domains of memory (immediate and delayed recall) and speed of processing across 
these studies. Participants also identified their satisfaction with the CT programs.  
Data Quality and Analysis 
The level of evidence of the individual studies ranged from level II to level IV including 
well-designed RCTs to well-designed uncontrolled, case control or cohort studies. 50 Areas for 
improvement in future research include inclusion of attention control comparison, standardized 
assessment and definition of impairment (and thus, improvement) and addressing multiple 
outcome comparisons. 
DISCUSSION  
Implication for Research and Practice  
Cognitive rehabilitation programs, including CBT and CT programs have been used to 
address cognitive dysfunction in cancer survivors. Positive intervention effects have been noted 
on both subjective (self-reported cognitive function) and objective (performance on 
neurocognitive tests) assessments. These findings suggest that, although more work is needed, 
cognitive rehabilitation may benefit cancer survivors with cognitive dysfunction.  
CT, including computerized cognitive training programs, have been examined in more 
trials and with larger number of cancer survivors than other approaches. Based on the existing 
level of evidence, the Oncology Nursing Society has identified that cognitive training is ‘likely 
to be effective’ for addressing cognitive dysfunction in cancer survivors. 51 These findings are 
encouraging, especially when combined with evidence from studies in the well elderly and other 
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chronic-illness populations 52-55 that suggest that cognitive training interventions promote 
neuroplasticity (form synaptic connections in response to learning) and may be beneficial. 
However, more research is warranted. There is a genuine need for larger, multi-site, pragmatic 
trials to fully understand the impact of CT. 56,57 Research to date has been conducted with small, 
single-center samples and studies with inferior designs (no control arm or no contact/waitlist 
controls versus attention control). In addition, more work is needed to understand the requisite 
dose and need for booster training for optimal treatment recommendations. As identified 
previously, although positive intervention effects were noted, they were often immediate and 
waned over time. Future research should address these unknown areas, validate its effectiveness 
and identify optimal treatment (dose) recommendations.  
Overall, CBT, although tested in a smaller number of cancer survivors has shown 
promise as an option for addressing cognitive dysfunction after cancer and cancer treatment. 
Three main groups of researchers to date have been working to perfect programs to address 
cognitive concerns through psychoeducation, self-awareness, self-efficacy, and self-actualization 
methods. Similar to recommendations for CT, more research related to CBT is needed to 
establish it as an efficacious option for cancer survivors.  
Future Considerations 
Evidence based treatment options are needed to address the potentially debilitating 
effects of cognitive dysfunction after cancer treatment. Researchers and clinicians, including 
advance practice nurses and nurse clinicians, must consider important factors that will affect 
treatment effectiveness and uptake in the future. Three main issues that should be considered for 
the future in this area are cost, access, and vulnerable populations, such as our aging cancer 
population.   
COGNITIVE REHABILITATION  
Cost and Access  
Most of the CBT and CT interventions reported in this review were found to be feasible 
to recruit to, deliver and resulted in positive outcomes for cancer survivors; yet, few discussed 
the practical concerns of adopting and implementing these approaches on a larger scale. More 
research is needed regarding the access to and cost of these programs to deliver. Cancer and 
active cancer treatment already impact the cancer patient’s ability to work 58 and many 
experience long-term financial hardships. 59 Programs developed to address cognitive 
dysfunction should be aimed at not only improving cognitive function, but also take into 
consideration their impact on work-related outcomes. In addition, the direct cost of participation 
(e.g. gas, transportation, etc.) and opportunity costs (e.g. time away from work/family) 
associated with participation in CBT or CT must be minimized. It is noteworthy that many of the 
participants in the studies reviewed were well-educated and most likely in a higher 
socioeconomic status. Cognitive rehabilitation programs must be designed and tested with a 
more diverse group of cancer survivors and must take into consideration both the direct and 
indirect costs of cognitive treatment. As noted in the study conducted by Cherrier and colleagues, 
32 only 72% of the participants were able to attend all of the planned workshop sessions. These 
authors stressed more work is needed to enhance participation and address barriers, such as 
transportation costs to the center. 32 Ferguson and colleagues 27 re-designed their MAAT 
program from an in-person format to be delivered via video conferencing and found positive 
results in both participant satisfaction and cognitive outcomes. However, this intervention 
required a licensed psychiatrist for delivery, which may ultimately, be a concern for broad scale 
dissemination for those who are under- or un-insured. Computerized CT programs are 
commercially available, and thus, readily accessible via the web and downloadable mobile 
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applications; but, again these programs come with a cost that currently is not offset by insurance. 
Future design and implementation of cognitive rehabilitation programs must consider both cost 
and access to be successfully integrated into survivorship care.   
Vulnerable Population – Aging Cancer Survivors  
As the nation ages and expected survival from cancer improves, approximately two-thirds 
of all cancer survivors will be aged 65 years and over by 2020. 60 This rapidly aging population 
represents a significant challenge in providing cancer care in the future. Older cancer survivors 
may be more susceptible to cognitive dysfunction as a result of lower cognitive reserve. 61  In 
addition, family or informal caregivers may play an increased role for older survivors who often 
have more healthcare-related needs. 62 Quality care of the older cancer survivor should include a 
thorough geriatric assessment. 63 The nursing assessment and survivorship treatment plan must 
incorporate outcomes especially germane to older cancer survivors, namely maintaining 
cognitive and physical functioning and preserving quality of life. Future cognitive rehabilitation 
programs must be developed and implemented that incorporate approaches amenable to the older 
cancer survivor and their families.  
Conclusion  
 Cognitive rehabilitative approaches, including CBT and CT, may benefit cancer survivors 
with cognitive dysfunction. More research, including larger, multi-site pragmatic trials are 
needed that assess not only their effectiveness, but also the optimal dose, delivery, access, and 
cost of these programs. Advance practice nurses and nurse clinicians must play a crucial role in 
not only assessing for and identifying cognitive dysfunction in their patients, but also treating 
cognitive dysfunction, especially in the ever-increasing number of older cancer survivors. 
Routine assessments must include ruling out other treatable, confounding symptoms (depression, 
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anxiety, and sleep disturbance), as well as, understanding the latest evidence regarding treatment 
options. Although more research is needed, cognitive rehabilitation has been identified as a first-
line option by the NCCN, the Oncology Nursing Society, and more specifically, CT has 
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Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
diagram 
Records identified through database 
searching  


























 Records identified through 
reviews found via database 
searching 
(n=4) 








assessed for eligibility 
(n=31) 
Full-text articles excluded 
(n=4, intervention was not 
cognitive rehabilitation and 
or was a review article)  
Studies included in 
final synthesis 
(n=27) 
Table 1 Cognitive Rehabilitation for Cognitive Dysfunction in Cancer Survivors 
Author, year Population N Study Design Intervention Primary Outcome Results & Limitations 





















Independence: 6 (46%) patients increased 
independence during rehabilitation; 6 patients 
were unchanged; 1 decreased independence 
Productivity: 8 (62%) patients increased 
productivity; 4 were unchanged; 1 decreased 




























efficacy and metamemory 
Neurocognitive tests of 
memory  
Improvements in subjective memory and memory 
self-efficacy. 
No improvement in objective memory 
performance. 
Limitations: 
 Combined sample with chronic conditions,
only 11 cancer patients
 Small sample








realistic & less 
fearful about 
cognitive aging. 
8 sessions of 1.25 
hours each over 4 
weeks. 
Control – waitlist 
control 
Ferguson, et 
al.,  2007 25 
Breast cancer 
on average 8 
years post-
chemotherapy 
29 Pilot study, 
single arm 
























Neurocognitive tests of 
memory, attention, and 
executive function 
Significant reduction in self-reported cognitive 
problems  




 No control, single arm study
 Mostly white, highly educated sample













6 (50 minute) 
sessions of each 
for 2 weeks 
Subjective: Mood and 
quality of life 
Neurocognitive tests  of 
immediate and delayed 
memory, language, 
attention, and visuo-
construction completed at 
baseline only  
Improvement in mood 
Intervention feasible and reported satisfaction 
Limitations: 
 Small sample
 Control – no contact control, standard care
 Failure to complete neurocognitive follow-up
assessment to determine intervention effects
Gehring, et 




140 RCT Combination: 
Cognitive 

















Neurocognitive tests of 
attention, memory, visual 
memory, working 
memory, verbal fluency, 
and executive function  
Improvement in perceived cognitive function 
(reduced cognitive complaints) immediately and 
at 6 months post-intervention  
Improvement in attention and memory at 6 
months post-intervention only  
Limitations: 
 Failure to account for confounding factors
including tumor location, seizures, and
current medications












Group 1 - 
Strategies-group 






Neurocognitive tests of 
attention, divided 
attention, working 
memory, and sustained 
memory 
No Intervention effects 
Limitations:  
 The use of an inpatient setting may have
affected the outcome.
 Failure to address practice effects with























2hrs per week, 6 
weeks 
Neurocognitive tests of 
attention, verbal memory, 
verbal memory (total 
learning), sustained 
attention, psychomotor 
speed, and verbal fluency 
Improvement in verbal memory (total 
learning) 
No improvement in attention, verbal 
memory, sustained attention, 
psychomotor speed and verbal fluency 
Limitations: 
 Small sample
 No control, single arm
McDougall, et 



















30 minute practice 
Control - health 
training; frequency 




Neurocognitive tests of 
memory – visual, verbal 
memory, global cognition, 
daily functioning   
Improvement in memory confidence, greater 
capacity and decreased memory complaints. 
No neurocognitive improvement 
Visual memory improvement sustained over time 
and trends for improvement in verbal and global 
memory but not statistically significant.  
Limitations: 
 Small homogenous sample
Booster sessions 
consisted of four 
weekly mandatory 
two-hour sessions 
over one month  
Von Ah, et 















vs Waitlist control 
10 1-hour 




Neurocognitive tests of 
speed of processing and 
immediate, total and 
delayed memory 
Improvement in subjective cognitive function in 
ST immediate and 2-months post-intervention 
and MT immediate post-intervention 
MT had improvement in immediate and delayed 
memory compared to waitlist control 
ST had improvement in immediate and delayed 
memory as well as processing speed compared 
to waitlist control immediate and 2 months post-
intervention 
Limitations: 
 Control group-waitlist control
 No comparison between interventions
Ferguson, et 


















cognitive function  
Neurocognitive tests of 
memory, executive 
function & processing 
speed 
No improvement in self-reported cognitive 
function compared to control 
Significant improvement in memory (total recall) 
immediately and 2-months post-treatment 
Limitations: 
 Small sample, low power
 Control group-waitlist control




months to 5 
years post-
treatment  
27 One group pre-
test post-test 
design  










Neurocognitive tests of 
verbal & visual memory, 
attention, executive and 
visuospatial functioning, 
and processing speed 
Significant improvement in neurocognitive tests 
of memory and processing speed 
Effect size for change is moderate to high 










reduced it from 6 
to 5 sessions 
 Small sample































health, & cognitive 
function; fatigue, 
sleep, and well 
being  





cognitive function  
Neurocognitive tests of 
immediate memory, 
visuospatial, 
constructional, & delayed 
memory; visual attention 
& psychomotor speed 
Improvement in perceived health-related quality 
of life immediate post and 3 months 
Improvement in perceived cognitive function over 
time.  
Improvement in immediate & delayed memory 
immediate and 3 months post intervention 
Improved visuospatial skills immediate and 3 
months post-intervention 
Improvement in global cognition immediate and 3 
months post-intervention  
Neurocognitive test results: 8 participants met 
reliable change criteria (36.4%); 1 cancer control 
had reliable improvement (12.5%); no non-
cancer controls improved. 
Limitations: 
 Non-random allocation
 Assessors also conducted intervention
Cherrier, et. 











Neurocognitive tests of 
memory, attention, 
Improvement in self-reported cognitive 
impairment for intervention group 
Improvement in executive function (working 
memory); no improvement in memory  











group sessions, 1 
hour each 
executive function, 
processing speed  
Limitations: 
 Small sample
 No control for time & attention
 No objective Screening for cognitive
impairment
 Intent-to-treat analysis was not used
Kesler, et al., 
2013 39
Breast cancer 
at least 18 
months post-
chemotherapy 
41 RCT Cognitive Training: 










Neurocognitive tests of 
memory, attention,  
executive function, 
cognitive flexibility, verbal 
fluency, letter fluency, 
processing speed  
Improved perceived cognitive function 
(planning/organization and task monitoring) 
Improvement in cognitive flexibility, verbal 
fluency, letter fluency, and processing speed 
Limitations: 
 Small sample










retrieve words by 
category 
5 – 30 minute 
trials 
Neurocognitive tests of 





Improved verbal recall 
Increased activation on fMRI 
Limitations: 
 Small sample
 No control, single arm
Zucchella, et 
al., 2013 45 
Primary brain 
tumor 




Neurocognitive tests – 
visual attention, 
immediate recall, delayed 
recall, verbal memory, 




sessions over 4 
weeks  
speed of processing, 
verbal fluency, language, 
non-verbal reasoning 
 Small sample
 Delivered during inpatient rehabilitation
resulting in high costs of treatment
Goedendorp, 








cancer – with 
fatigue 













reaction time/speed of 
information processing 
and attention and 
concentration  
Improvement in subjective cognitive ability (less 
concentration problems and less disability) 
No improvement in neurocognitive tests 
Limitations: 
 Small sample
 Control group-waitlist control




months – 5 
years  
48 RCT See Erocoli, 2013 Subjective: cognitive 
complaints 
Neurocognitive tests: 
memory (total and 
delayed recall) executive 
function – cognitive 
flexibility, working 
memory, inhibition, 
complex reaction time, 
speed of processing, 
motor ability  
EEG 
Improvement in subjective cognitive complaints 
Improvement in memory (total and delayed 
recall) at 2 months 
Limitations: 
 Small sample


















cognitive function  
Neurocognitive tests: 





Improvement in perceived cognitive function in 
both groups over time.  
Improvement in speed of processing immediate 





health, & cognitive 
function; fatigue, 
sleep, and well 
being  




Control – waitlist 
control 
skills, and global 
cognition  
 Control group-waitlist control
Damholdt, et 
al., 2016 40 
Breast cancer 
survivors  
157 RCT Cognitive Training: 
computerized 
cognitive training - 
Happyneuron Pro, 





 30 minutes/day, 5 







Working memory – 
primary outcome 
Verbal memory, learning, 
verbal fluency, attention, 
executive functioning – 
problem solving 
No improvement of perceived cognitive function 
Improvement in verbal learning at 5 months and 




 Control group-waitlist control
Ferguson, et 
al., 2016 27 
Breast cancer 
survivors 
47 RCT Cognitive 
Rehabilitation 
(See Ferguson et 
al., 2009) 
Control: attention 





processing speed and 
verbal memory 
Improvement in perceived cognitive function 2 
months post-intervention  
Improvement in processing speed immediately 
post-intervention, no improvement in processing 
speed at follow-up and verbal memory at either 
time points  
Limitations: 
 Small sample

















cognitive function  
Neurocognitive tests: 




working memory, verbal 
fluency in category, and 
verbal fluency in letter, 
processing speed, 
language  
Improvement noted in perceived cognitive 
function  
Improvements noted in immediate memory, 
delayed memory, verbal fluency in category, and 
verbal fluency in letter  
Limitations: 
 Small sample
 Control – waitlist control














memory, speed of 
processing 
(InSight Program) 
4 – 40minute per 




cognitive function  
Neurocognitive test – 
memory, attention, 
executive function-
working memory, problem 
solving, & new learning, 
processing speed   
Improvement in perceived cognitive function. 




 14% enrolled did not complete the program





















speed, daily functioning 
Improvement in perceived cognitive function 
(decreased self-report of cognitive concerns) 
Limitations: 
 Small sample





+ 45minute CT 3-4
times per week
Wu, et al., 
2018 47
Prostate 60 RCT Cognitive training: 
BrainHQ® 
40 1-hour session 





executive function – 
cognitive flexibility, 
attention, processing 
speed, motor ability 
Improvement in processing speed immediately 
post and 2-months post-intervention 




 Control – waitlist control














Control – waitlist 
control & active 
community control 
Subjective: perceived 
cognitive function  
Neurocognitive tests: 





Improved perceived cognitive function post-
intervention 




al., 2018 41 
Breast cancer 
survivors 





speed of processing and 
executive functioning 
Improvement of speed of processing and 




 Control – no contact control
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